Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Election of Class II Directors: Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D..
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Proposal No. 1 - Election of Class II Directors: The stockholders of the Company elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D., as Class II directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2029 and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-12-31
Exact text from the filing
Proposal No. 2 - Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026: The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
Proposal No. 3 - Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers: The stockholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
View on SEC.gov